Xtant Medical Holdings, Inc., a global medical technology company focused on surgical solutions for the treatment of spinal disorders, has acquired the nanOss production operations from RTI Surgical, Inc., a contract development and manufacturing organization (CDMO) in regenerative medicine. Under the terms of the purchase agreement, Xtant acquired certain assets, including equipment and inventory, used in RTI’s synthetic bone graft business, and assumed from RTI the lease for the nanOss prod...